| - GRCh37:
- Chr3:49498433-55348528
- GRCh38:
- Chr3:49461000-55314500
| ABHD14A, ABHD14A-ACY1, ABHD14B, ACTR8, ACY1, ALAS1, AMIGO3, APEH, BAP1, BSN, BSN-DT, C3orf18, CACNA1D, CACNA2D2, CACNA2D3, CACNA2D3-AS1, CAMKV, CDHR4, CHDH, CISH, CYB561D2, DAG1, DCAF1, DCP1A, DNAH1, DOCK3, DUSP7, ESRG, GLT8D1, GLYCTK, GLYCTK-AS1, GMPPB, GNAI2, GNAT1, GNL3, GPR62, GRM2, HEMK1, HYAL1, HYAL2, HYAL3, IFRD2, IL17RB, INKA1, IP6K1, IQCF1, IQCF2, IQCF3, IQCF5, IQCF5-AS1, IQCF6, ITIH1, ITIH3, ITIH4, ITIH4-AS1, LINC00696, LINC02017, LINC02019, LINC02030, LOC101928965, LOC110121103, LOC110121200, LOC110121270, LOC112935947, LOC112935948, LOC112935949, LOC112935950, LOC114004379, LOC114004380, LOC115995511, LOC121009668, LOC121009669, LOC121009670, LOC121009671, LOC121009672, LOC121725145, LOC121725146, LOC122889088, LOC122889089, LOC122889090, LOC122965306, LOC122965307, LOC122965308, LOC122965309, LOC122965310, LOC122965311, LOC126806677, LOC126806678, LOC126806679, LOC126806680, LOC126806681, LOC126806682, LOC126806683, LOC126806684, LOC126806685, LOC126806686, LOC126806687, LOC127898564, LRTM1, LSMEM2, MANF, MAPKAPK3, MIR135A1, MIR4787, MIR5193, MIR566, MIR5787, MIR6872, MIR8064, MIRLET7G, MON1A, MST1, MST1R, MUSTN1, NAA80, NEK4, NISCH, NPRL2, NT5DC2, PARP3, PBRM1, PCBP4, PHF7, POC1A, PPM1M, PRKCD, RAD54L2, RASSF1, RASSF1-AS1, RBM15B, RBM5, RBM5-AS1, RBM6, RFT1, RNF123, RPL29, RRP9, SELENOK, SEMA3B, SEMA3B-AS1, SEMA3F, SEMA3F-AS1, SEMA3G, SFMBT1, SLC38A3, SNORD136, SNORD19, SNORD19B, SNORD19C, SNORD38C, SNORD69, SPCS1, STAB1, STIMATE, STIMATE-MUSTN1, TEX264, TKT, TLR9, TMEM115, TNNC1, TRAIP, TUSC2, TWF2, TWF2-DT, UBA7, UQCC5, WDR82, ZMYND10 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr3:51431865-55098476
- GRCh38:
- Chr3:51394434-55064449
| ABHD14A, ABHD14A-ACY1, ABHD14B, ACTR8, ACY1, ALAS1, BAP1, CACNA1D, CACNA2D3, CACNA2D3-AS1, CHDH, DCAF1, DCP1A, DNAH1, DUSP7, ESRG, GLT8D1, GLYCTK, GLYCTK-AS1, GNL3, GPR62, GRM2, IL17RB, IQCF1, IQCF2, IQCF3, IQCF5, IQCF5-AS1, IQCF6, ITIH1, ITIH3, ITIH4, ITIH4-AS1, LINC00696, LOC110121103, LOC110121270, LOC112935947, LOC112935948, LOC112935949, LOC112935950, LOC114004379, LOC114004380, LOC115995511, LOC121009672, LOC121725145, LOC121725146, LOC122889090, LOC122965306, LOC122965307, LOC122965308, LOC122965309, LOC122965310, LOC122965311, LOC126806678, LOC126806679, LOC126806680, LOC126806681, LOC126806682, LOC126806683, LOC126806684, LOC126806685, LOC126806686, LRTM1, MIR135A1, MIR8064, MIRLET7G, MUSTN1, NEK4, NISCH, NT5DC2, PARP3, PBRM1, PCBP4, PHF7, POC1A, PPM1M, PRKCD, RAD54L2, RBM15B, RFT1, RPL29, RRP9, SELENOK, SEMA3G, SFMBT1, SNORD136, SNORD19, SNORD19B, SNORD19C, SNORD38C, SNORD69, SPCS1, STAB1, STIMATE, STIMATE-MUSTN1, TEX264, TKT, TLR9, TNNC1, TWF2, TWF2-DT, UQCC5, WDR82 | | See cases | Likely pathogenic (Oct 22, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr3:52485105
- GRCh38:
- Chr3:52451089
| TNNC1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485164
- GRCh38:
- Chr3:52451148
| TNNC1 | | not provided, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z
| Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:52485168
- GRCh38:
- Chr3:52451152
| TNNC1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485208
- GRCh38:
- Chr3:52451192
| TNNC1 | | not provided, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
| Benign/Likely benign (Jan 13, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485214
- GRCh38:
- Chr3:52451198
| TNNC1 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485216
- GRCh38:
- Chr3:52451200
| TNNC1 | | Dilated cardiomyopathy 1Z, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Hypertrophic cardiomyopathy 13 | Uncertain significance (Aug 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485283
- GRCh38:
- Chr3:52451267
| TNNC1 | | not provided | Uncertain significance (Nov 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485294
- GRCh38:
- Chr3:52451278
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485297
- GRCh38:
- Chr3:52451281
| TNNC1 | | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, not specified
| Likely benign (Jul 20, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485301
- GRCh38:
- Chr3:52451285
| TNNC1 | G159D | not provided | Likely pathogenic (Jan 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485303
- GRCh38:
- Chr3:52451287
| TNNC1 | | Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
| Likely benign (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485304
- GRCh38:
- Chr3:52451288
| TNNC1 | K158R | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Aug 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485304
- GRCh38:
- Chr3:52451288
| TNNC1 | K158T | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485307
- GRCh38:
- Chr3:52451291
| TNNC1 | M157R | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Jul 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485308
- GRCh38:
- Chr3:52451292
| TNNC1 | M157V | Dilated cardiomyopathy 1Z | Uncertain significance (Oct 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485308
- GRCh38:
- Chr3:52451292
| TNNC1 | M157L | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiovascular phenotype, not provided | Uncertain significance (Sep 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485308
- GRCh38:
- Chr3:52451292
| TNNC1 | M157L | Primary dilated cardiomyopathy | Uncertain significance (Sep 29, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:52485321
- GRCh38:
- Chr3:52451305
| TNNC1 | E152D | not provided, Cardiovascular phenotype | Uncertain significance (Nov 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485321
- GRCh38:
- Chr3:52451305
| TNNC1 | | not specified, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiomyopathy | Likely benign (Sep 11, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485327
- GRCh38:
- Chr3:52451311
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Jun 12, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485328
- GRCh38:
- Chr3:52451312
| TNNC1 | | not provided, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
| Conflicting interpretations of pathogenicity (Sep 2, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:52485336
- GRCh38:
- Chr3:52451320
| TNNC1 | | not specified | Benign (Jul 5, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485340
- GRCh38:
- Chr3:52451324
| TNNC1 | | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Likely benign (Nov 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485341
- GRCh38:
- Chr3:52451325
| TNNC1 | | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Likely benign (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485390
- GRCh38:
- Chr3:52451374
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485391
- GRCh38:
- Chr3:52451375
| TNNC1 | | not specified | Uncertain significance (May 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485392
- GRCh38:
- Chr3:52451376
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485400-52485401
- GRCh38:
- Chr3:52451384-52451385
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Dec 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485400
- GRCh38:
- Chr3:52451384
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiomyopathy
| Conflicting interpretations of pathogenicity (Aug 14, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:52485401
- GRCh38:
- Chr3:52451385
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not specified
| Conflicting interpretations of pathogenicity (Jun 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:52485401
- GRCh38:
- Chr3:52451385
| TNNC1 | | not specified, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
| Uncertain significance (Mar 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485404
- GRCh38:
- Chr3:52451388
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Nov 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485407
- GRCh38:
- Chr3:52451391
| TNNC1 | E152K | Dilated cardiomyopathy 1Z | Pathogenic (Apr 30, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr3:52485409
- GRCh38:
- Chr3:52451393
| TNNC1 | D151V | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485415
- GRCh38:
- Chr3:52451399
| TNNC1 | D149G | not provided | Uncertain significance (Jul 18, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485416
- GRCh38:
- Chr3:52451400
| TNNC1 | D149N | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not specified, not provided | Uncertain significance (Apr 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485417
- GRCh38:
- Chr3:52451401
| TNNC1 | | Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
| Likely benign (Jan 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485417
- GRCh38:
- Chr3:52451401
| TNNC1 | | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Conflicting interpretations of pathogenicity (Aug 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:52485419
- GRCh38:
- Chr3:52451403
| TNNC1 | I148V | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, not specified, Primary dilated cardiomyopathy | Uncertain significance (Jun 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485421
- GRCh38:
- Chr3:52451405
| TNNC1 | R147H | Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
| Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485422
- GRCh38:
- Chr3:52451406
| TNNC1 | R147C | Cardiomyopathy | Uncertain significance (May 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485425
- GRCh38:
- Chr3:52451409
| TNNC1 | G146R | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485425
- GRCh38:
- Chr3:52451409
| TNNC1 | G146C | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485425
- GRCh38:
- Chr3:52451409
| TNNC1 | G146S | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiovascular phenotype
| Uncertain significance (Oct 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485426
- GRCh38:
- Chr3:52451410
| TNNC1 | | Cardiovascular phenotype, not specified, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided | Likely benign (Jan 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485426
- GRCh38:
- Chr3:52451410
| TNNC1 | D145E | Cardiovascular phenotype, not provided, not specified, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiomyopathy
| Uncertain significance (Jun 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485428
- GRCh38:
- Chr3:52451412
| TNNC1 | D145H | Cardiomyopathy | Uncertain significance (Jan 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485428
- GRCh38:
- Chr3:52451412
| TNNC1 | D145N | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided
| Uncertain significance (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485429
- GRCh38:
- Chr3:52451413
| TNNC1 | | Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided | Likely benign (Jul 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485429-52485431
- GRCh38:
- Chr3:52451413-52451415
| TNNC1 | N144del | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not specified
| Uncertain significance (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485430
- GRCh38:
- Chr3:52451414
| TNNC1 | N144S | not specified | Uncertain significance (Feb 7, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr3:52485431
- GRCh38:
- Chr3:52451415
| TNNC1 | N144D | Hypertrophic cardiomyopathy 13, Cardiovascular phenotype, not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy | Conflicting interpretations of pathogenicity (Jun 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:52485435
- GRCh38:
- Chr3:52451419
| TNNC1 | K142N | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485436-52485437
- GRCh38:
- Chr3:52451420-52451421
| TNNC1 | K142fs | Cardiovascular phenotype | Uncertain significance (May 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485442
- GRCh38:
- Chr3:52451426
| TNNC1 | G140E | Cardiovascular phenotype, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z
| Uncertain significance (Apr 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485443
- GRCh38:
- Chr3:52451427
| TNNC1 | G140R | Cardiovascular phenotype, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z
| Uncertain significance (Apr 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485444
- GRCh38:
- Chr3:52451428
| TNNC1 | | Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiomyopathy | Likely benign (Jan 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485445
- GRCh38:
- Chr3:52451429
| TNNC1 | D139G | Cardiovascular phenotype | Uncertain significance (Apr 28, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485445
- GRCh38:
- Chr3:52451429
| TNNC1 | D139A | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485457
- GRCh38:
- Chr3:52451441
| TNNC1 | E135A | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485459
- GRCh38:
- Chr3:52451443
| TNNC1 | | Cardiovascular phenotype | Likely benign (Jan 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485459
- GRCh38:
- Chr3:52451443
| TNNC1 | E134D | Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not specified, not provided | Uncertain significance (Jan 11, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485461
- GRCh38:
- Chr3:52451445
| TNNC1 | E134K | Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided | Uncertain significance (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485462
- GRCh38:
- Chr3:52451446
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485464
- GRCh38:
- Chr3:52451448
| TNNC1 | I133V | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485465
- GRCh38:
- Chr3:52451449
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485465-52485467
- GRCh38:
- Chr3:52451449-52451451
| TNNC1 | D132del | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485467
- GRCh38:
- Chr3:52451451
| TNNC1 | D132N | not specified | Uncertain significance (Jul 6, 2012) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485468
- GRCh38:
- Chr3:52451452
| TNNC1 | D131E | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485468
- GRCh38:
- Chr3:52451452
| TNNC1 | | not provided, Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiomyopathy | Likely benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485474
- GRCh38:
- Chr3:52451458
| TNNC1 | | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Likely benign (Feb 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485474
- GRCh38:
- Chr3:52451458
| TNNC1 | | Cardiovascular phenotype, not specified, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Conflicting interpretations of pathogenicity (Mar 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:52485475
- GRCh38:
- Chr3:52451459
| TNNC1 | T129M | Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided | Uncertain significance (Jun 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485477
- GRCh38:
- Chr3:52451461
| TNNC1 | | Cardiomyopathy, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
| Likely benign (Mar 26, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485478
- GRCh38:
- Chr3:52451462
| TNNC1 | I128T | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485485
- GRCh38:
- Chr3:52451469
| TNNC1 | E126K | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided, Cardiomyopathy | Uncertain significance (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485486
- GRCh38:
- Chr3:52451470
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiovascular phenotype
| Likely benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485486
- GRCh38:
- Chr3:52451470
| TNNC1 | | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Likely benign (May 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485489
- GRCh38:
- Chr3:52451473
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Jan 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485491
- GRCh38:
- Chr3:52451475
| TNNC1 | T124P | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Sep 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485497-52485499
- GRCh38:
- Chr3:52451481-52451483
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Jan 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485497-52485498
- GRCh38:
- Chr3:52451481-52451482
| TNNC1 | Q122fs | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Jun 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485498
- GRCh38:
- Chr3:52451482
| TNNC1 | | Cardiovascular phenotype | Likely benign (Jan 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485505
- GRCh38:
- Chr3:52451489
| TNNC1 | I119T | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Jun 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485506
- GRCh38:
- Chr3:52451490
| TNNC1 | I119V | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485507
- GRCh38:
- Chr3:52451491
| TNNC1 | K118N | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485507
- GRCh38:
- Chr3:52451491
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Jan 29, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485510
- GRCh38:
- Chr3:52451494
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485513
- GRCh38:
- Chr3:52451497
| TNNC1 | E116D | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485520
- GRCh38:
- Chr3:52451504
| TNNC1 | L114R | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiovascular phenotype
| Uncertain significance (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485522
- GRCh38:
- Chr3:52451506
| TNNC1 | D113E | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485523-52485539
- GRCh38:
- Chr3:52451507-52451523
| TNNC1 | A108fs | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485524
- GRCh38:
- Chr3:52451508
| TNNC1 | D113fs | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Feb 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485524
- GRCh38:
- Chr3:52451508
| TNNC1 | D113N | not provided, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z
| Uncertain significance (Mar 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485525
- GRCh38:
- Chr3:52451509
| TNNC1 | I112M | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485525
- GRCh38:
- Chr3:52451509
| TNNC1 | | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely benign (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485527
- GRCh38:
- Chr3:52451511
| TNNC1 | I112V | Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, not provided
| Uncertain significance (Aug 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52485533
- GRCh38:
- Chr3:52451517
| TNNC1 | G110C | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |